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Background: Patients are commonly referred to tertiary centers for deep enteroscopy because of abnormal ﬁndings on video capsule endoscopy (VCE).
The aim of this study was to determine how often clinical management changes when VCEs are reviewed by an enteroscopist prior to scheduling a
procedure.
Methods: A retrospective review was performed of patients referred for deep enteroscopy because of abnormal capsule endoscopy. All VCE images were
reviewed prospectively by the tertiary center’s enteroscopist. Patients were then scheduled for deep enteroscopy or other management based on the
capsule review. The rate of disagreement in the capsule ﬁndings, changes in management, and the diagnostic and therapeutic yield of enteroscopy were
calculated.
Results: Video capsule endoscopy was available in 45 patients who were referred for deep enteroscopy. The mean age was 61 years (51% were females).
Indications included obscure GI bleeding (37 patients), abnormal imaging (3 patients), abdominal pain (2 patients), Peutz-Jegher syndrome (2 patients),
and weight loss (1 patient). Referring physician ﬁndings included polyps or masses (13 patients), angioectasia (13 patients), ulcers (9 patients), active
bleeding (9 patients), nonspeciﬁc ﬁndings (8 patients), and normal (2 patients). A capsule review led to disagreement of the ﬁndings of 13 (29%) patients
and led to a change in the management of 9 (20%) patients. The most common reason for a change in management was overcalled lesions. Thirty-seven
patients underwent enteroscopy with a diagnostic yield of 48.8% and therapeutic intervention in 24.4%.
Conclusion: A review of referral VCE studies led to a change in management in a large percentage of patients, particularly when the indication was polyp,
mass, or ulcer. Patients referred for deep enteroscopy should have their capsule re-read by an enteroscopist prior to scheduling the procedure.
Copyright  2014, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved.
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Video capsule endoscopy (VCE) is widely used in the community
for the diagnosis of small bowel disorders. However, deep entero-
scopy is generally only performed at tertiary care centers. Thus,
when lesions are found that require deep enteroscopy, patients are
referred to a tertiary center, often in an open-access manner. Pro-
cedures are commonly scheduled, based on the referring physician’s
interpretation of the capsule ﬁndings, but precise anatomic loca-
tions of lesions, route of insertion (i.e., antegrade vs. retrograde), and
interpretation of capsule ﬁndings may be unspeciﬁed or incorrect.
At our institution, we reviewed capsule endoscopies prior to
scheduling procedures to determine whether deep enteroscopy
versus another endoscopic or nonendoscopic test is required, and
determine the best route of insertion. Patients are referred in an
open-access manner, although only those who will likely beneﬁt
from deep enteroscopy (as determined by the enteroscopist) are
scheduled for the procedure. Our primary aim was to determine
how often changes in clinical management are made for patientsDivision of Gastroenterology and Hepatology, Medical University of South Carolina, Charlest
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by the enteroscopist prior to scheduling the procedure.
Methods
Patients and variables
We conducted a retrospective analysis of all patients referred to
the Medical University of South Carolina (Charleston, SC, USA) be-
tween July 2011 and February 2013 fordeep enteroscopy inwhomthe
video capsule disc was available for review. Patients were excluded if
the VCE had not been reviewed by the enteroscopist before sched-
uling the procedure. This study was approved by the Institutional
Review Board of the Medical University of South Carolina.
Video capsule endoscopy
All capsule endoscopies included in this study used the PillCam
SB2 capsule system (Given Imaging, Yoqneam, Israel). No otheron, SC, USA
T 7100A, Charleston, SC, 29425, USA.
on. Published by Elsevier. All rights reserved.
Table 1 Patient Characteristics and Vce Indications and Findings
Demographics
Mean age, y (range) 61 (18–79)
Female 23
Male 22
Indications for VCE
Obscure GI bleeding 37
Abnormal imaging 3
Peutz-Jegher syndrome 2
Abdominal pain 2
Weight loss 1
VCE ﬁndings, n *
Polyps/masses 13
Angioectasia 13
Active bleeding 9
Ulcers 9
Nonspeciﬁc mucosal abnormality 8
Normal 2
VCE, video capsule endoscopy.
* The VCE ﬁndings are by the referring physician.
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were excluded based on the capsule manufacturer. Capsules were
not always made available by the referring physician or, for some
patients, were sent on an unreadable disc. In this eventuality, pa-
tients were excluded from analysis for this study.
All capsules were ﬁrst reviewed by the referring physician, and
then reviewed prospectively by a single tertiary care physician
(A.S.B.), who reads approximately 100 VCEs per year. The capsules
were reviewed in their entirety, with a particular focus on
abnormal areas thumb-nailed by the referring physician. Inter-
pretation of the capsule ﬁndings was prospectively recorded on
RAPID for PillCam software (Given Imaging, Yoqneam, Israel).
Enteroscopy
Enteroscopy was performed by a single endoscopist (ASB, who
performs over 100 deep enteroscopies annually), by using a single
balloon system (SIF-180; Olympus Medical, Center Valley, PA, USA).
Antegrade and retrograde approaches were determined at the
discretion of the endoscopist. The standard technique was used.1Table 2 Discordant Findings
Referring physician interpretation Requested
procedure
Capsule rev
1 No source of bleeding encountered ASBE Angioectasia at 9%, 20
2 Proximal small bowel ulcer ASBE Angioectasias in the d
proximal jejunum, pr
and mid-ileum. Bubbl
rather than ulcer
3 Multiple submucosal nodules and polyps
throughout the small bowel
ASBE All folds
4 Angioectasias and ulcerated lesions in the
duodenum
PE Erythema and focal sw
8% into the small bow
5 Submucosalmass in the mid-small bowel ASBE Reversed view of the
than submucosal lesio
Enteropathy
6 Small bowel polyp ASBE Colonic fold
7 Distal duodenal angioectasias and gastritis PE Angioectasias in the m
8 Multiple small bowel angioectasias; ulcer ASBE Multiple small bowel
no ulcer
9 Mass/lipoma in the mid-small bowel ASBE Duodenal angioectasi
was light reﬂex artifa
10 Ileal ulcer ASBE Food debris; no ulcer
11 Possible jejunal angioectasia 2nd opinion Normal
12 Submucosal lesion in the distal ileum 2nd opinion Fold rather than subm
13 Jejunal ulcer ASBE Ulcer in mid-ileum
APC, argon plasma coagulation; ASBE, antegrade single balloon enteroscopy; N/a, not apData analysis
Data were obtained from the RAPID for PillCam database (Given
Imaging), endoscopy database, and institutional electronic medical
records. The data collected included the indications for capsule
endoscopy, VCE interpretation by the referring physician, VCE
interpretation by the tertiary care physician, the results of entero-
scopy and/or other subsequent tests, and the demographic data.
The rate of disagreement in the capsule ﬁndings and rate of changes
in management, and the diagnostic yield of therapeutic in-
terventions in patients undergoing deep enteroscopy were
calculated.
Results
Outside VCE discs were available for 45 patients who were
referred for deep enteroscopy. All patients were included in this
analysis. The mean age of the patients was 61 years (18–79 years)
and 23 (51%) patients were female (Table 1). Indications for VCE
included obscure GI bleeding (37 patients), abnormal imaging (3
patients), abdominal pain (2 patients), Peutz-Jegher syndrome (2
patients), and weight loss (1 patient). The referring physician
ﬁndings included polyps or masses (13 patients), angioectasia (13
patients), ulcers (9 patients), active bleeding (9 patients), nonspe-
ciﬁc ﬁndings (8 patients), and normal (2 patients). Many patients
had more than one ﬁnding. Thirty-eight (84.4%) patients were
referred for antegrade single balloon enteroscopy (ASBE); 3 (6.7%)
patients, for retrograde single balloon enteroscopy (RSBE); 2 (4.4%)
patients, for push enteroscopy; and 2 (4.4%) patients, for a second
opinion.
Capsule review led to disagreement in the ﬁndings of 13 (28.8%)
patients (Table 2). Of these 13 patients with discordant ﬁndings,
there were 11 overcalled lesions, ﬁve missed lesions, and three
lesions with misidentiﬁed locations. Most patients had multiple
discordant ﬁndings. Overcalled lesions included masses or polyps
(5 patients; Figs. 1 and 2); ulcers (4 patients); and angioectasias (2
patients). Missed lesions included angioectasias (2 patients; Fig. 3);
gastric antral vascular ectasia (GAVE)/portal hypertensive gastro-
pathy and enteropathy (1 patient); and nonspeciﬁc enteropathy (1
patient).iew Procedure Findings
%, and 72% ASBE Normal
uodenum,
oximal ileum
e artifact
ASBE Angioectasias in the duodenum
and jejunum treated with APC
Observation N/a
elling/mass
el
ASBE Normal
pylorus rather
n.
ASBE Normal
Colonoscopy to exclude polyp Normal colonoscopy
id-jejunum ASBE Normal small bowel
angioectasias; Enteroscopy deferred because
of multiple comorbidities and
no ulcer present
N/a
as. The “mass”
ct
ASBE Duodenal and jejunal
angioectasias treated with APC
present Enteroscopy deferred N/a
Enteroscopy deferred N/a
ucosal lesion Enteroscopy deferred. N/a
RSBE Benign ulcer in the mid-ileum
plicable; PE, push enteroscopy; RSBE, retrograde single balloon enteroscopy.
Fig. 1. Fold misidentiﬁed as a mass. Fig. 3. Missed angioectasia.
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Conservative management was recommended for two patients
secondary to overcalled lesions. There were two additional patients
who were also treated with conservative management because of
overcalled lesions; however, these patients were referred for a
second opinion and could not be counted as a change in manage-
ment. Overcalled lesions included polyps, masses, or angioectasias
that were actually folds, insigniﬁcant erythema, light reﬂex, or food
debris. Two patients with multiple small bowel angioectasias were
recommended to have conservative management because of mul-
tiple comorbidities and/or lack of the need for blood transfusion.
One patient was deferred for enteroscopy in favor of cross-sectional
imaging; magnetic resonance enterography revealed a carcinoid
tumor and the patient subsequently underwent its surgical resec-
tion. Two patients underwent ASBE instead of push enteroscopyFig. 2. Light reﬂex misidentiﬁed as a mass.and one patient underwent RSBE instead of ASBE because of a
misidentiﬁed lesion location. One patient underwent repeat colo-
noscopy instead of ASBE because of a lesion that was read as a small
bowel polyp but was actually a colonic fold. In total, 37 patients
underwent enteroscopy with a diagnostic yield of 48.8% and ther-
apeutic intervention of 24.4%. There were no immediate or delayed
adverse events.
Discussion
Capsule endoscopy is becoming increasingly common for the
initial investigation of suspected small bowel pathology.2 The
relative ease, low risk, and minimal training requirements have
made it widely available in academic settings and in private prac-
tice settings. Abnormal ﬁndings often require deep enteroscopy,
which is typically only available at tertiary care centers. Patients are
often referred in an open-access manner, which is acceptable as
long as there is a good indication. At our institution, we re-read
capsules whenever possible, particularly if there is doubt about
the indication.
In this study, we found that changes in management after re-
reading capsule endoscopies were because of lesion misdiagnosis,
incorrect lesion location, or inappropriate route of insertion
requested. Diagnostic errors may result from a lack of experience
and training in capsule endoscopy, but even among experts there is
interobserver variability in capsule interpretation.3–5 It has been
previously suggested that a second reading by an experienced
viewer may improve the diagnostic accuracy of VCE.6 An inaccurate
lesion location may result from a lack of familiarity with the length
of each small bowel segment or result from the use of gross time
estimates rather than small bowel transit time, as discussed below.
Improper recommended route of insertion is likely to be secondary
to a lack of understanding of the depth limitations of antegrade
and/or retrograde enteroscopy. Enteroscopists may have an
advantage in determining lesion location/route of insertion and in
recognizing small bowel pathology on VCE because they regularly
visualize the correlating lesions during enteroscopy. Previous
studies have not compared VCE interpretation between endo-
scopists who perform enteroscopy and those who do not.
Capsule endoscopy differs from other imagingmodalities in that
it can only give an estimate of where a lesion may be in the small
Table 3 Changes in Management
Referring physician interpretation Requested
procedure
Capsule review Management change Outcome
1 Multiple submucosal nodules and polyps ASBE All folds Enteroscopy deferred N/a
2 Angioectasias and ulcerated lesion in the
duodenum
PE Erythema and focal swelling/mass
8% into the small bowel
ASBE Normal
3 Small bowel polyp ASBE Colonic fold Colonoscopy to exclude polyp Normal
4 Distal duodenal angioectasias and gastritis PE Angioectasias in the mid-jejunum ASBE Normal small bowel
5 Multiple small bowel angioectasias; ulcer ASBE Multiple small bowel angioectasias;
no ulcer
Enteroscopy deferred because of
multiple comorbidities and lack of ulcer
Iron therapy
6 Ileal ulcer ASBE Food debris; no ulcer Enteroscopy deferred N/a
7 Ulcerated mass versus ulcer with edema in
proximal to the mid-ileum
ASBE Ulcerated mucosal mass in proximal
to the mid-ileum
Enteroscopy deferred. MRE performed Ileal carcinoid tumor;
surgery
8 Multiple proximal small bowel angioectasias ASBE Multiple proximal small bowel AVMs Enteroscopy deferred because no blood
transfusions were required
N/a
9 Jejunal ulcer ASBE Ulcer in mid-ileum RSBE Benign ulcer in the
mid-ileum
ASBE, antegrade single balloon enteroscopy; AVMs; MRE, magnetic resonance enterography; N/a, not applicable; PE, push enteroscopy; RSBE, retrograde single balloon
enteroscopy.
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developed. By using the ﬁrst duodenal image and ﬁrst cecal image,
each small bowel image is given an estimated percentage of small
bowel covered out of the total small bowel transit. This technique
has been validated for determining the route of insertion for
enteroscopy. For example, lesions up to 36% through the small
bowel can be reliably reached by ASBE.7Most readers, however, still
use gross time through the bowel, rather than the percent progress,
to estimate a lesion’s anatomic location. This technique does not
take into account gastric transit time or pauses in capsule move-
ment because of stricture or lack of peristalsis. These errors may
lead to an inaccurate estimation of lesion location and subsequent
incorrect mode of enteroscopy. Disagreement in lesion location led
to a change in management in two (4.4%) patients in this study.
There is a signiﬁcant false positive rate with capsule endos-
copy.3,8,9 This is particularly true with polyps and ulcers, although
angioectasias and masses are also frequently overcalled.3,10–12
Criteria have been developed to help differentiate submucosal tu-
mors from folds; however, the criteria remain a very challenging
aspect of VCE.13,14 Our studywas consistent with these observations
in that the most common overcalled lesions were masses/polyps5
and ulcers.4 There were also three instances in which angioecta-
sias were present that were missed or mistaken for erosions or ul-
cers. These patients underwent ASBE for a different indication than
originally intended, but the overall management was not changed.
The limitations of this study include the small number of pa-
tients and readings were performed by a single enteroscopist at a
single center. Our results nonetheless demonstrate that reviewing
capsule endoscopies prior to enteroscopy results in a substantial
number of changes in management. These changes are not insig-
niﬁcant in that they may lead to a different route of insertion, a
different modality (e.g., cross-sectional imaging), or obviate the
need for further work-up. If abstracted to a larger scale, re-reading
could substantially decrease cost, resource utilization, and the
performance of potentially unnecessary procedures. In conclusion,
reviewing capsule endoscopies in patients referred for open-access
enteroscopy changes management in a large proportion of patients.
If not employed for all patients, this process should at least be
performed when there is any doubt as to the indication for
enteroscopy or route of insertion.Conﬂicts of interest
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